SOX2 and osteosarcoma: Given that aberrant SOX2 expression has been strongly implicated as a critical oncogenic driver in osteosarcoma (OS),24–28 our objective was to identify and characterize the signaling pathways responsible for inducing SOX2 overexpression in OS.